Basal cell carcinoma: Cultivation potential and results of chromosome aberrations analysis;Bazocelularni karcinom: Mogućnosti kultivaci je i rezultati analize hromosomskih aberacija

HealthMED

Volumn 4, Issue 3, 2010, Pages 605-609

  Ibrulj, S ^a   Haveric, A ^b   Haveric, S ^b   Rahmanovic, A ^b   Alendar, F ^c  

^a UNIVERSITY OF SARAJEVO   (Bosnia and Herzegovina)

^b Institute for Genetic Engineering and Biotechnology   (Bosnia and Herzegovina)

^c UNIVERSITY OF SARAJEVO   (Bosnia and Herzegovina)

Author keywords

Basal cell carcinoma; Cell culture; Chromosome aberrations

Indexed keywords

EID: 77957370509     PISSN: 18402291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Barch M.J., Knutsen T., Spurbeck J.L. (1997) The AGT Cytogenetics Laboratory Manual. Lippincott-Raven, Philadelphia.
2. Natarajan A.T., Boei J.J.W.A., Darroudi F., Van Diemen P.C.M., Dolout F., Handle M.P., Ramalho A.T. (1996) Current cytogenetic methods for detecting exposure and effects of mutagens and carcinogens. Environ Health Perspect. 104 (3), 445-448.
3. Campbell N.A., Reece J.B., Taylor M.R., Simon E.J. (2006) Biology, concepts and conections. Pearson Education Inc., San Francisco.
4. Brysk M.M., Santschi C.H., Bell T., Wagner R.F. Jr., Tyring S.K., Rajaraman S. (1992) Culture of basal cell carcinoma. J Invest Dermatol. 98(1), 45-49.
5. Hernandez A.D., Hibbs M.S., Postlethwaite A.E. (1985) Establishment of basal cell carcinoma in culture: evidence for a basal cell carcinoma-derived factor(s) which stimulates fibroblasts to proliferate and release collagenase. J Invest Dermatol. 85(5), 470-475.
6. Jin Y., Mertens F., Persson B., Warloe T., Gullestad H.P., Salemark L., Jin C., Jonsson N., Risberg B., Mandahl N., Mitelman F., Heim S. (1998) Nonrandom numerical chromosome abnormalities in basal cell carcinomas. Cancer Genet Cytogenet. 103(1), 35-42.
7. Mitelman F. (1995) ISCN, An International System for Human Cytogenetic Nomenclature. Cytogenetics and Cell genetics. S. Karger, Basel.
8. Hagmar, L., Stromberg, U., Bonassi, S., Hansteen, I.L., Knudsen, L.E., Lindholm, C., Norppa, H. (2004) Impact of types of lymphocyte chromosomal aberrations on human cancer risk: results from Nordic and Italian cohorts. Cancer Res. 64,2258-2263.
9. Rossner, P., Boffetta, P., Ceppi, M., Bonassi, S., Smerhovsky, Z., Landa, K., Juzova, D., Sram, R.J. (2005) Chromosomal aberrations in lymphocytes of healthy subjects and risk of cancer. Environ Health Perspect. 113(5), 517-520.
10. Hagmar L, Stromberg U, Tinnerberg H, Mikoczy Z (2001) The usefulness of cytogenetic biomarkers as intermediate endpoints in carcinogenesis. Int J Hyg Environ Health. 204, 43-47.
11. Duesberg, P., Rasnick, D. (2000) Aneuploidy, the somatic mutation that makes cancer a species of its own. Cell Motil Cytoskeleton. 47(2), 81-107.
12. Li, R., Sonik, A., Stindl, R., Rasnick, D., Duesberg, P. (2000) Aneuploidy vs. gene mutation hypotesis of cancer: Recent study claims mutation but is found to support aneuploidy. Proc Nat Acad Sci U S A. 97(7), 3236-3241.
13. Gebhart E. (2005) Double minutes, cytogenetic equivalents of gene amplification, in human neo-plasia - a review. Clin Transl Oncol. 7(11), 477-485.